We are live on
!
Find out more
RxSight
RXST
RXST
Fund managers haven’t disclosed any holdings of RXST yet.
RXST Hedge Fund Activity: Q1 2026 in Review
164 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q1 2026, worth a combined $235M — down 38% from $382M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new RXST positions and 31 closed out — a net gain of 3 holders — while 63 added to existing stakes and 54 trimmed.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, adding an estimated $8.3M. The largest seller was Defilade Capital Management, exiting entirely with an estimated $9.51M sold.
- 164 institutional investors held RxSight (RXST) as of Q1 2026, up from 163 in Q4 2025.
- Funds reported $235M of RxSight stock for Q1 2026, down 38% quarter-over-quarter.
- 34 funds opened new RxSight positions in Q1 2026 and 31 closed out, a net change of +3 holders.
- The largest RxSight buyer in Q1 2026 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $8.3M added.
- The largest RxSight seller in Q1 2026 was Defilade Capital Management, an estimated $9.51M sold.
Based on aggregated 13F filings for Q1 2026.